Individuals Discontinuing Anti-Obesity Jabs Put On Pounds Far More Rapidly Than Those on Conventional Diets

Fresh analysis indicates that individuals who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds far faster than those who end traditional lifestyle regimens.

Research printed in a leading health publication shows that while overweight individuals can lose a large proportion of their body weight while using the jabs, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"People buying these treatments need to be informed of the potential of rapid weight regain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

That rate of recovery means a reversion to pre-treatment mass within about 18 months.

Analyzing Approaches

The study, which looked at 37 of trials involving thousands of participants, contrasted the outcomes of these new drugs with older methods.

The team note that individuals who shed pounds through diet and exercise usually experience a slower weight regain—approximately 100 grams monthly—after stopping.

Explaining the Rapid Regain

Doctors believe the mechanism of the injections accounts for the amplified regain.

GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to produce less of its endogenous GLP-1, and may also lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement results in hunger is uncontrolled, making binge eating far more likely."

An Ongoing Condition?

Health authorities advise the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

A number of clinicians contend that, given the high risk of relapse, the therapy is often ongoing.

This view is reinforced by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," akin to managing diseases like high blood pressure.

User Testimonies

Users who have come off the medication report a sudden resurgence of hunger.

"It felt as if a trigger that goes on and you become starving," said a patient.

This difficulty is compounded if patients have not adopted sustainable dietary or behavioural changes during therapy.

Widespread Use

Figures show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.

• Adoption is more common among females compared to males.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion access the medications through private prescriptions rather than public health services.

Ultimately, clinicians emphasize that while the jabs are powerful tools for weight loss, they are not a magic fix and long-term success likely depends on combined behavioural changes.